-
公开(公告)号:US12246096B2
公开(公告)日:2025-03-11
申请号:US17296187
申请日:2019-11-20
Applicant: The Regents of the University of California
Inventor: Ryan Baxter , Sayantani Ghosh
Abstract: Self-assembled organic ligand functionalized microcapsules encapsulating one or more substrates, which release the substrates upon activation with a power source, are provided. Compositions that include these microcapsules, as well as methods of making the microcapsules and releasing the encapsulated substrates are also provided. The structures, compositions and methods find use in a variety of applications, such as drug and cell encapsulation technologies, for direct delivery, control, and activation of medicines and therapies to specific tissues in a living host.
-
公开(公告)号:US20250075275A1
公开(公告)日:2025-03-06
申请号:US18681427
申请日:2022-08-05
Applicant: The Regents of the University of California
Inventor: John McPherson , Maija Kiuru
IPC: C12Q1/6886 , C12Q1/6841 , G16B25/10
Abstract: Provided herein are methods for locating and characterizing a melanoma tumor by detecting expression levels of one or both of S100A8 and S100A9. The provided methods are particularly useful for evaluating spatially specific properties of the tumor, and for using this information to locate the border of the tumor, surgically removing the tumor, or treat the tumor by administering a particularly determined dosage of a therapeutic agent.
-
公开(公告)号:US12243297B2
公开(公告)日:2025-03-04
申请号:US17597714
申请日:2020-07-20
Applicant: The Regents of the University of California
Inventor: Jitendra Malik , Pratik Mukherjee , Esther L. Yuh , Wei-Cheng Kuo , Christian Haene
IPC: G06V10/82 , G06T7/00 , G06V10/764 , G06V10/774
Abstract: A computer-implemented method can include a training phase and a hemorrhage detection phase. The training phase can include: receiving a first plurality of frames from at least one original computed tomography (CT) scan of a target subject, wherein each frame may or may not include a visual indication of a hemorrhage, and further wherein each frame including a visual indication of a hemorrhage has at least one label associated therewith; and using a fully convolutional neural network (FCN) to train a model by determining, for each of the first plurality of frames, whether at least one sub-portion of the frame includes a visual indication of a hemorrhage and classifying the sub-portion of the frame based on the determining. The hemorrhage detection phase can include: receiving a second plurality of frames from a CT scan of a target subject, wherein each frame may or may not include a visual indication of a hemorrhage; and determining, for each of the second plurality of frames, whether a plurality of sub-portions of the frame includes a visual indication of a hemorrhage based at least in part on the trained model.
-
公开(公告)号:US12239694B2
公开(公告)日:2025-03-04
申请号:US18215276
申请日:2023-06-28
Applicant: The Regents of the University of California
Inventor: Dena Dubal
Abstract: Provided herein are klotho polypeptide compositions and methods for improving cognitive function in an individual comprising treatment of with klotho polypeptides.
-
公开(公告)号:US12239455B2
公开(公告)日:2025-03-04
申请号:US18160995
申请日:2023-01-27
Inventor: Jeffrey C. Lotz , James Clayton Peacock, III , David S. Bradford , Stefan Dudli , Sergey G. Magnitsky
IPC: A61B5/00 , A61B5/055 , G01R33/46 , G01R33/465 , G01R33/48 , G01R33/483 , G01R33/485 , G01R33/56
Abstract: An MR Spectroscopy (MRS) system and approach is provided for measuring spectral information corresponding with propionic acid (PA), either alone or in combination with other measurements corresponding with other chemicals, to diagnose and/or monitor at least one of bacterial infection, such as associated with P. acnes, or conditions related thereto such as nociceptive pain associated with tissue acidity. An interfacing DDD-MRS signal processor receives output signals to produce a post-processed spectrum, with spectral regions corresponding with certain chemicals, including PA, then measured as biomarkers. A diagnostic processor derives a diagnostic value for each disc, and performs certain normalizations, based upon ratios of the spectral regions related to chemicals implicated in degenerative painful tissue pathology, such as PA and hypoxia markers of lactic acid (LA) and alanine (AL), and structural chemicals of proteoglycan (PG) and collagen or carbohydrate (CA).
-
公开(公告)号:US20250069520A1
公开(公告)日:2025-02-27
申请号:US18627039
申请日:2024-04-04
Applicant: The Regents of the University of California
Inventor: Adam Gazzaley
IPC: G09B19/00 , A61B3/11 , A61B5/00 , A61B5/0205 , A61B5/024 , A61B5/0533 , A61B5/055 , A61B5/083 , A61B5/11 , A61B5/16 , A61B5/369 , A63B24/00 , A63B26/00 , A63F13/211 , A63F13/213 , A63F13/85 , G09B7/02
Abstract: Provided are methods that include presenting to a subject an embodied cognitive task that includes a cognitive component and a physical component. The methods further include assessing the subject's performance on each of the cognitive component and the physical component, and adapting the difficulty level of the embodied cognitive task based on the subject's performance on each of the cognitive component and the physical component. In certain aspects, the methods find use in enhancing cognition, physical fitness, or both, in a subject. Also provided are methods of treating and diagnosing cognitive disorders. Systems and computer readable media for practicing the methods of the present disclosure are also provided.
-
公开(公告)号:US20250064903A1
公开(公告)日:2025-02-27
申请号:US18034622
申请日:2021-10-29
Inventor: Ingrid Swanson PULTZ , Clancey WOLF , Justin Bloomfield SIEGEL , Christine Elaine TINBERG , Lance STEWART , David BAKER
Abstract: The present disclosure is directed to polypeptides capable of cleaving gluten proteins, e.g., gliadins, nucleic acid molecules encoding the same, pharmaceutical compositions comprising the same, and methods of use thereof for treating celiac sprue disease and/or non-celiac gluten sensitivity (NCGS).
-
公开(公告)号:US12236688B2
公开(公告)日:2025-02-25
申请号:US17738678
申请日:2022-05-06
Inventor: Pavel Tokmakov , Allan Jabri , Adrien D. Gaidon
Abstract: A method for tracking occluded objects includes encoding locations of a plurality of objects in an environment, determining a target object, receiving a first end point corresponding to a position of the target object before occlusion behind an occlusion object, distributing a hypothesis between both sides of the occlusion object during occlusion from a subsequent frame of the sequence of frames, receiving a second end point corresponding to a position of the target object after emerging from occlusion from another subsequent frame of the sequence of frames, and determining a trajectory of the target object when occluded by the occlusion object by performing inferences using a spatio-temporal probabilistic graph based on the current frame and the subsequent frames of the sequence of frames. The trajectory of the target object when occluded is used as a learning model for future target objects that are occluded by the occlusion object.
-
公开(公告)号:US12233407B2
公开(公告)日:2025-02-25
申请号:US18161322
申请日:2023-01-30
Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Inventor: Dino Di Carlo , Chueh-Yu Wu
IPC: B01L3/02 , B01L3/00 , C12N1/04 , C12N5/071 , C12N5/0783 , C12Q1/6806 , G01N33/543
Abstract: Sub-millimeter scale three-dimensional (3D) structures are disclosed with customizable chemical properties and/or functionality. The 3D structures are referred to as drop-carrier particles. The drop-carrier particles allow the selective association of one solution (i.e., a dispersed phased) with an interior portion of each of the drop-carrier particles, while a second non-miscible solution (i.e., a continuous phase) associates with an exterior portion of each of the drop-carrier particles due to the specific chemical and/or physical properties of the interior and exterior regions of the drop-carrier particles. The combined drop-carrier particle with the dispersed phase contained therein is referred to as a particle-drop. The selective association results in compartmentalization of the dispersed phase solution into sub-microliter-sized volumes contained in the drop-carrier particles. The compartmentalized volumes can be used for single-molecule assays as well as single-cell, and other single-entity assays.
-
公开(公告)号:US12233090B2
公开(公告)日:2025-02-25
申请号:US18623246
申请日:2024-04-01
Inventor: Yvonne Y. Chen , Eugenia Zah , Michael C. Jensen
IPC: A61K35/17 , A61K39/00 , C07K14/705 , C07K14/725 , C07K16/28 , C07K16/46 , C12N5/0783 , A61K38/00
Abstract: A CD20-OR-CD19 chimeric antigen receptor (CAR) protein construct is provided. Also provided are nucleic acids encoding the CD20-OR-CD19 CAR; and methods of use, e.g. in the treatment of B cell malignancies. The CD20-OR-CD19 CAR of the invention is a bispecific CAR that can trigger T-cell activation upon detection of either CD19 or CD20 (or both). It is a single molecule that confers two-input recognition capability upon human T cells engineered to stably express this CAR.
-
-
-
-
-
-
-
-
-